By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – A majority of clinical geneticists in Europe are concerned that genetic tests marketed directly to consumers are not clinically useful, and a large percentage believe that sales of certain types of DTC tests should be more closely regulated or banned, according to a study presented today at the European Society of Human Genetics conference in Amsterdam.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nature this week: association between genome-wide homozygosity and traits like height and cognitive ability, improved CRISPR-Cas9 editing, and more.

A survey examines how age, political leanings, and more influence how Americans view certain scientific topics, the Associated Press reports.

A researcher who pleaded guilty to making false statements in research reports has been sentenced to four and a half years in prison and must pay $7.2 million back to the NIH.

The BabySeq project to study the risks and benefits of sequencing newborns is underway.